Lixte Biotechnology
LIXT
LIXT
15 hedge funds and large institutions have $363K invested in Lixte Biotechnology in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
44% less capital invested
Capital invested by funds: $652K → $363K (-$289K)
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$18.8K | |
| 2 | +$7K | |
| 3 | +$2.44K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.52K |
| 5 |
Jane Street
New York
|
+$1.44K |